85 related articles for article (PubMed ID: 2159401)
1. Autoimmune reactions in a patient with malignant insulinoma treated by multiple low dose streptozotocin.
Schulz B; Hehmke B; Zander E; Ziegler B
Exp Clin Endocrinol; 1990 Feb; 95(1):77-82. PubMed ID: 2159401
[TBL] [Abstract][Full Text] [Related]
2. Treatment of malignant metastatic pancreatic insulinoma with streptozotocin. Review of 21 cases described in detail in the literature and report of complete remission of a new case.
Herbai G; Lundin A
Acta Med Scand; 1976; 200(6):447-52. PubMed ID: 189576
[TBL] [Abstract][Full Text] [Related]
3. Multiple low-dose streptozotocin-induced diabetes in the mouse. Evidence for stimulation of a cytotoxic cellular immune response against an insulin-producing beta cell line.
McEvoy RC; Andersson J; Sandler S; Hellerström C
J Clin Invest; 1984 Sep; 74(3):715-22. PubMed ID: 6088584
[TBL] [Abstract][Full Text] [Related]
4. Studies on the chemical and immunological destruction of insulin-secreting islet cell tumours.
Flatt PR; Shibier O; Ioannides C; Swanston-Flatt SK
Exp Clin Endocrinol; 1989 May; 93(2-3):193-202. PubMed ID: 2550268
[TBL] [Abstract][Full Text] [Related]
5. Scoparia dulcis, a traditional antidiabetic plant, protects against streptozotocin induced oxidative stress and apoptosis in vitro and in vivo.
Latha M; Pari L; Sitasawad S; Bhonde R
J Biochem Mol Toxicol; 2004; 18(5):261-72. PubMed ID: 15549711
[TBL] [Abstract][Full Text] [Related]
6. [Zollinger-Ellison syndrome and metastatic insulinoma; its response to streptozotocin].
Agular-Parada E; Rivadeneyra-Hinojosa J; Guzman-Patraca C; Salas-Montero J; Escalante-Herrera A
Arch Invest Med (Mex); 1977; 8(1):31-8. PubMed ID: 192163
[TBL] [Abstract][Full Text] [Related]
7. Survival of islet isografts despite cytotoxicity against pancreatic islets measured in vitro.
Ziegler B; Köhler E; Klöting I; Besch W; Ziegler M
Exp Clin Endocrinol; 1990 Feb; 95(1):31-8. PubMed ID: 2139850
[TBL] [Abstract][Full Text] [Related]
8. Expression and immune response to islet antigens following treatment with low doses of streptozotocin in H-2d mice.
Herold KC; Baumann E; Vezys V; Buckingham F
J Autoimmun; 1997 Feb; 10(1):17-25. PubMed ID: 9080296
[TBL] [Abstract][Full Text] [Related]
9. In vitro natural killer cell activity in the spontaneously diabetic BB/Wor rat: effects of serum on lysis of insulinoma cells.
Koevary SB
Diabetes Res; 1988 Jun; 8(2):77-84. PubMed ID: 2852569
[TBL] [Abstract][Full Text] [Related]
10. Streptozotocin effective for treating multiple-hormone-producing malignant islet cell tumor.
Murata E; Tashiro S; Hiraoka T
Jpn J Surg; 1985 Jan; 15(1):63-7. PubMed ID: 2985854
[TBL] [Abstract][Full Text] [Related]
11. Genetic control of diabetes induction by complete Freund's adjuvant combined with subdiabetogenic doses of streptozotocin in Lewis rats--evidence for transient cytotoxicity against beta cells.
Ziegler B; Tietz S; Kohnert KD; Köhler E; Knospe S; Klöting I; Ziegler M
Exp Clin Endocrinol; 1987 Aug; 89(3):269-75. PubMed ID: 2959492
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of streptozotocin-induced islet cell tumors and N-nitrosobis(2-oxopropyl)amine-induced pancreatic exocrine tumors in Syrian hamsters by exogenous insulin.
Pour PM; Kazakoff K; Carlson K
Cancer Res; 1990 Mar; 50(5):1634-9. PubMed ID: 2154330
[TBL] [Abstract][Full Text] [Related]
13. Heterogeneity of islet cell autoantibodies in terms of insulin release from rat islets and insulinoma cells.
Ejiri K; Taniguchi H; Morimoto Y; Yamashiro Y; Baba S; Srikanta S; Eisenbarth GS
Diabetes Res Clin Pract; 1990 Apr; 9(1):1-5. PubMed ID: 2161728
[TBL] [Abstract][Full Text] [Related]
14. Effect of cerebrocrast, a new long-acting compound on blood glucose and insulin levels in rats when administered before and after STZ-induced diabetes mellitus.
Briede J; Stivrina M; Stoldere Dz; Vigante B; Duburs G
Cell Biochem Funct; 2007; 25(6):673-80. PubMed ID: 16986170
[TBL] [Abstract][Full Text] [Related]
15. Flow-cytometric detection of human anti-rat insulinoma antibodies in relation to anti-human islet cell and anti-insulin antibodies. Recognition of distinct antigens by antibodies in early type I diabetes.
Lander T; Nerl C; Held M; Standl E; Mehnert H
Diabetes; 1989 Dec; 38(12):1557-66. PubMed ID: 2555242
[TBL] [Abstract][Full Text] [Related]
16. Insulin-induced immunohistochemical and morphological changes in pancreatic beta-cells of streptozotocin-treated diabetic rats.
Adewole SO; Ojewole JA
Methods Find Exp Clin Pharmacol; 2007 Sep; 29(7):447-55. PubMed ID: 17982509
[TBL] [Abstract][Full Text] [Related]
17. S-methyl-L-thiocitrulline counteracts interleukin 1 beta induced suppression of pancreatic islet function in vitro, but does not protect against multiple low-dose streptozotocin-induced diabetes in vivo.
Sternesjö J; Welsh N; Sandler S
Cytokine; 1997 May; 9(5):352-9. PubMed ID: 9195135
[TBL] [Abstract][Full Text] [Related]
18. Beta-cell apoptosis is responsible for the development of IDDM in the multiple low-dose streptozotocin model.
O'Brien BA; Harmon BV; Cameron DP; Allan DJ
J Pathol; 1996 Feb; 178(2):176-81. PubMed ID: 8683386
[TBL] [Abstract][Full Text] [Related]
19. DNA strand breaks and poly(ADP-ribose) synthetase activation in pancreatic islets--a new aspect to development of insulin-dependent diabetes and pancreatic B-cell tumors.
Okamoto H; Yamamoto H
Princess Takamatsu Symp; 1983; 13():297-308. PubMed ID: 6317640
[TBL] [Abstract][Full Text] [Related]
20. Destruction of pancreatic beta cells in rats by complete Freund's adjuvant combined with non-diabetogenic doses of streptozotocin.
Kohnert KD; Odselius R; Fält K; Ziegler B; Ziegler M; Falkmer S
Diabetes Res; 1987 May; 5(1):1-11. PubMed ID: 2957141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
